Gilead Sciences is the cheapest of the major US biotechnology firms but its low cost is well-justified as the firm’s HCV franchise is in free-fall and the other drugs in the portfolio cannot offset the drag in the short term. In the longer term though we believe Gilead shares could be primed for recovery.
Join everyone on Discord!
Trade Stocks, FX, Gold, Oil & More with Bitcoin on 1Broker.uk
Get a Bitcoin MasterCard here to take out your Crypto-profits CASH in ATM-Machines worldwide!